Financial Consulate
WST icon

Financial Consulate’s West Pharmaceutical WST Stock Holding History

Financial Consulate’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.85K Buy
+5
New +$1.76K ﹤0.01% 1137
2026
Q1 		– Sell
-1,014
Closed -$279K – 1495
2025
Q4 		$279K Sell
1,014
-328
-24% -$89.7K 0.04% 128
2025
Q3 		$352K Buy
+1,342
New +$326K 0.05% 117
2023
Q2 		– Sell
-599
Closed -$208K – 122
2023
Q1 		$208K Buy
+599
New +$175K 0.07% 117

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Financial Consulate's WST Position: Q3 2026 in Review

Financial Consulate opened a new position in West Pharmaceutical (WST) in Q3 2026: 5 shares worth $1.85K. The stake represents ﹤0.01% of the portfolio and ranks #1137 among its holdings. This is a return to the name: Financial Consulate previously reported a position in WST as recently as Q4 2025.

Financial Consulate first reported a position in WST in Q1 2023 and has held it in 4 quarters since. The position peaked at $352K in Q3 2025. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Financial Consulate held 5 shares of West Pharmaceutical worth $1.85K as of Q3 2026.
  • West Pharmaceutical was a new Financial Consulate position in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1137 holding.
  • Financial Consulate first reported a position in West Pharmaceutical in Q1 2023 and has held it in 4 quarters since.
  • Financial Consulate's West Pharmaceutical position peaked at $352K in Q3 2025.
  • 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.